These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 232024

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Evaluation of surgical response in renovascular hypertension using angiotensin II blockade.
    Buda JA, Baer L, Arora SP, Parra-Carrillo JZ, Radichevich I.
    Surgery; 1978 Nov; 84(5):664-70. PubMed ID: 715682
    [Abstract] [Full Text] [Related]

  • 23. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA, Drayer JI, Priest RT, Chen TC.
    Am J Nephrol; 1982 Nov; 2(1):6-11. PubMed ID: 6295161
    [Abstract] [Full Text] [Related]

  • 24. [Saralasin-induced changes of blood pressure, renin and aldosterone in essential and renal hypertension (author's transl)].
    Beyer J, Liebau G, Steiner B, Hayduk K.
    Klin Wochenschr; 1978 Sep 01; 56(17):859-64. PubMed ID: 713415
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Saralasin infusion in renovascular hypertension: increased response rate in seated patients.
    Tucker RM, Sheps SG, Brennan LA.
    Mayo Clin Proc; 1980 Feb 01; 55(2):99-102. PubMed ID: 7354651
    [Abstract] [Full Text] [Related]

  • 30. Saralasin infusion in the recognition of renovascular hypertension.
    Wilson HM, Wilson JP, Slaton PE, Foster JH, Liddle GW, Hollifield JW.
    Ann Intern Med; 1977 Jul 01; 87(1):36-42. PubMed ID: 879617
    [Abstract] [Full Text] [Related]

  • 31. Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): the role of factors other than renin-angiotensin blockade in the rat.
    Marks ES, Bing RF, Thurston H, Swales JD.
    Clin Sci (Lond); 1980 Jan 01; 58(1):1-6. PubMed ID: 6986224
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Usefulness of converting enzyme inhibitors in diagnosis of renovascular hypertension. I. Comparison of the effect of angiotensin converting enzyme inhibition on blood pressure and plasma renin activity in patients with primary hypertension and renovascular hypertension].
    Posadzy-Małaczyńska A.
    Przegl Lek; 1997 Jan 01; 54(5):314-9. PubMed ID: 9380805
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Humoral effects of the oral converting-enzyme inhibitor SQ 14,225 in hypertensive patients in supine and tilted position.
    Morganti A, Pickering TG, Lopez-Ovejero J, Laragh JH.
    Clin Sci (Lond); 1979 Dec 01; 57 Suppl 5():149s-152s. PubMed ID: 232018
    [No Abstract] [Full Text] [Related]

  • 37. Effect of the converting-enzyme inhibitor SQ 14 225 (captopril) in early one-kidney, one-clip hypertension in the rat.
    Vandongen R, Tunney A, Martinez P.
    Clin Sci (Lond); 1981 Apr 01; 60(4):387-92. PubMed ID: 7018794
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.